Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
4.49
Nov 19 • 3:59 PM ET Dollar change+0.21 Percentage change(4.91%)
Aftermarket Close
4.49
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
9.46M
Enterprise Value
5.54M
Income
-7.73M
Sales
0.19M
Book/sh
2.87
Cash/sh
1.72
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
7
IPO
Oct 10, 2006
P/E
-
Forward P/E
-
PEG
-
P/S
49.80
P/B
1.57
P/C
2.61
P/FCF
-
EV/EBITDA
-
EV/Sales
29.17
Quick Ratio
10.60
Current Ratio
10.60
Debt/Eq
0.02
LT Debt/Eq
0.01
Option/Short
No / Yes
EPS (ttm)
-5.28
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
18.80% 14.16%
Sales past 3/5Y
40.34% 17.53%
EPS Y/Y TTM
46.85%
Sales Y/Y TTM
-68.50%
EPS Q/Q
61.24%
Sales Q/Q
-100.00%
Insider Own
2.96%
Insider Trans
0.00%
Inst Own
12.17%
Inst Trans
0.96%
ROA
-134.21%
ROE
-150.28%
ROIC
-161.36%
Gross Margin
48.98%
Oper. Margin
-3862.94%
Profit Margin
-3985.58%
SMA20
12.21%
SMA50
28.89%
SMA200
-46.81%
Trades
Shs Outstand
2.11M
Shs Float
2.04M
52W High
21.60 -79.21%
52W Low
2.43 84.77%
Volatility
10.08% 11.75%
ATR (14)
0.47
RSI (14)
57.63
Beta
0.49
Rel Volume
0.38
Avg Volume
72.03K
Volume
27,486
Perf Week
7.42%
Perf Month
59.22%
Perf Quarter
-58.86%
Perf Half Y
-50.57%
Perf YTD
-51.49%
Perf Year
-72.79%
Perf 3Y
-77.15%
Perf 5Y
-94.63%
Perf 10Y
-95.84%
Prev Close
4.28
Price
4.49
Change %
4.91%
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the IP licensing segment which generates revenue from customers by licensing its proprietary DehydraTECH technology. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
CEO & DirectorMr. Richard C. Christopher
Chairman of the Scientific Advisory BoardMr. John M. Docherty M.Sc.
Chief Financial OfficerMr. Michael Shankman CPA
Director of OperationsMs. Kristin Hamilton
Head of LegalMs. Vanessa Carle